Adjunctive eslicarbazepine acetate in pediatric patients with focal epilepsy: A systematic review and meta-analysis
CNS Drugs | Mar 26, 2018
Lattanzi S, et al. - The efficacy and safety of eslicarbazepine acetate as an add-on treatment for focal-onset seizures were evaluated in pediatric patients using meta-analytical techniques. Findings suggested the potential of adjunctive eslicarbazepine acetate as an effective well-tolerated option in children and adolescents with focal-onset seizures uncontrolled by one or more concomitant anti-epileptic drugs.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries